Researchers used real-world data to identify key factors for long-term weight loss for patients taking GLP-1 drugs like Ozempic and Wegovy.

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Plus: The story behind the award-winning science that led to Ozempic, the next astronaut launch and why homework is good for ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small ...

Three scientists are honoured for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Kids as young as six years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity ...